209 related articles for article (PubMed ID: 1640597)
41. Tuberculosis drug resistance in Canakkale, Turkey.
Gonlugur T; Basol G; Gonlugur U
Cent Eur J Public Health; 2020 Sep; 28(3):245. PubMed ID: 32997482
[No Abstract] [Full Text] [Related]
42. [Therapy of pulmonary tuberculosis in its current aspects].
Gartmann JC
Bibl Tuberc; 1965; 20():59-70. PubMed ID: 4291161
[No Abstract] [Full Text] [Related]
43. Short-course treatment regimens for patients with tuberculosis.
Dutt AK; Stead WW
Arch Intern Med; 1980 Jun; 140(6):827-9. PubMed ID: 6770770
[No Abstract] [Full Text] [Related]
44. [Bactericidal therapy in patients with tuberculosis].
Krasnov VA; Ursov IG
Probl Tuberk Bolezn Legk; 2004; (3):21-6. PubMed ID: 15338895
[No Abstract] [Full Text] [Related]
45. Primary drug resistance: a continuing study of drug resistance in tuberculosis in a veteran population within the United States. X. September 1970 to September 1973.
Hobby GL; Johnson PM; Boytar-Papirnyik V
Am Rev Respir Dis; 1974 Jul; 110(1):95-8. PubMed ID: 4209360
[No Abstract] [Full Text] [Related]
46. Use of molecular techniques to distinguish between treatment failure and exogenous reinfection with Mycobacterium tuberculosis.
Krüüner A; Pehme L; Ghebremichael S; Koivula T; Hoffner SE; Mikelsaar M
Clin Infect Dis; 2002 Jul; 35(2):146-55. PubMed ID: 12087520
[TBL] [Abstract][Full Text] [Related]
47. [Proceedings: Tuberculosis therapy. Review on today's knowledge, developmental trends and still open problems].
Eule H; Krebs A; Iwainsky H
Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):78-100. PubMed ID: 4131870
[No Abstract] [Full Text] [Related]
48. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
Toungoussova S; Caugant DA; Sandven P; Mariandyshev AO; Bjune G
Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916
[TBL] [Abstract][Full Text] [Related]
49. The suitability of new drugs for intermittent chemotherapy of tuberculosis. An experimental study.
Dickinson JM
Scand J Respir Dis Suppl; 1969; 69():91-8. PubMed ID: 4190279
[No Abstract] [Full Text] [Related]
50. [Principles underlying the use of antituberculosis medication in children (author's transl)].
Ollivier A; Besson-Leaud M
Sem Hop; 1979 Oct 8-15; 55(33-34):1529-35. PubMed ID: 229564
[TBL] [Abstract][Full Text] [Related]
51. [Kanamycin and florimycin in the clinical course of pulmonary tuberculosis].
Bialik IB
Antibiotiki; 1971 Feb; 16(2):184-8. PubMed ID: 4326728
[No Abstract] [Full Text] [Related]
52. [Duration of the after-control of the tuberculous patients following the termination of the treatment].
Neumann G
Wien Med Wochenschr; 1972 Dec; 122(51):764-8. PubMed ID: 4346497
[No Abstract] [Full Text] [Related]
53. Extra-pulmonary primary multidrug-resistant tubercular lymphadenitis in an HIV negative patient.
Kant S; Saheer S; Hassan G; Parengal J
BMJ Case Rep; 2012 May; 2012():. PubMed ID: 22605844
[TBL] [Abstract][Full Text] [Related]
54. Antituberculous drug resistance in central Haiti.
Scalcini M; Carré G; Jean-Baptiste M; Hershfield E; Parker S; Wolfe J; Nelz K; Long R
Am Rev Respir Dis; 1990 Sep; 142(3):508-11. PubMed ID: 2117870
[TBL] [Abstract][Full Text] [Related]
55. Individualising therapy for drug-sensitive tuberculosis.
Esmail H; Lipman MC; Nunn A; Walker TM
Lancet Respir Med; 2019 Oct; 7(10):834-835. PubMed ID: 31427253
[No Abstract] [Full Text] [Related]
56. Drug-induced heart failure in advanced pulmonary tuberculosis.
Daynes G
S Afr Med J; 1974 Nov; 48(57):2352-3. PubMed ID: 4432186
[No Abstract] [Full Text] [Related]
57. Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family.
Bifani PJ; Plikaytis BB; Kapur V; Stockbauer K; Pan X; Lutfey ML; Moghazeh SL; Eisner W; Daniel TM; Kaplan MH; Crawford JT; Musser JM; Kreiswirth BN
JAMA; 1996 Feb; 275(6):452-7. PubMed ID: 8627966
[TBL] [Abstract][Full Text] [Related]
58. Short-course chemotherapy for pulmonary tuberculosis.
Fox W; Mitchison DA
Am Rev Respir Dis; 1975 Mar; 111(3):325-53. PubMed ID: 47233
[No Abstract] [Full Text] [Related]
59. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 2. Results of rifampicin treatment for advanced pulmonary tuberculosis patients resistant to conventional antituberculous drugs].
Kekkaku; 1971 Nov; 46(11):423-8. PubMed ID: 4335256
[No Abstract] [Full Text] [Related]
60. [Pulmonary tuberculosis resistant to streptomycin and isoniazid and treated wtih a combination of ethionamide, pyrazinamide, and cycloserine (200 cases)].
Bartal M; Nejjar A; Laraki A
Tunis Med; 1973 Jul; 51(4):237-43. PubMed ID: 4209977
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
